Related Experiment Video
Updated: Jul 18, 2025

10:46
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
10.7K
Serological Biomarker-Based Machine Learning Models for Predicting the Relapse of Ulcerative Colitis
Wenwen Pang1, Bowei Zhang2, Leixin Jin3
1Department of Clinical Laboratory, Tianjin Union Medical Center, Nankai University, Tianjin, People's Republic of China.
Journal of Inflammation Research
|August 28, 2023
Summary
Machine learning models accurately predict Ulcerative colitis (UC) relapse using serological markers. This offers a noninvasive tool for personalized treatment plans and improved patient outcomes.
Area of Science:
- Gastroenterology
- Biomedical Informatics
- Computational Biology
Background:
- Ulcerative colitis (UC) relapse poses a significant challenge in patient management.
- Predicting UC relapse is crucial for timely intervention and personalized treatment strategies.
Purpose of the Study:
- To evaluate the efficacy of machine learning models utilizing serological markers for predicting Ulcerative colitis relapse.
- To compare the performance of different machine learning algorithms in UC relapse prediction.
Main Methods:
- A cohort study involving 292 UC patients, collecting serological markers at hospital discharge.
- Development and comparison of four machine learning models: random forest (RF), logistic regression, decision tree, and neural network.
- Performance evaluation using accuracy, sensitivity, specificity, and AUC.
Main Results:
- The random forest model demonstrated the highest predictive performance with an AUC of 0.889 in the test group.
- The best-performing model achieved 76.4% accuracy, 78.5% sensitivity, and 76.4% specificity.
- Key predictors identified include age, hemoglobin concentration, white blood cell count, and platelet distribution width.
Conclusions:
- Machine learning models incorporating serological markers provide a highly accurate, noninvasive method for predicting UC relapse.
- These models can aid in optimizing patient outcomes and guiding personalized therapeutic decisions.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
173
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
173
Inflammatory Bowel Disease I: Ulcerative Colitis
213
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
213

